Tirzepatide is a dual-agonist , meaning it works by targeting two hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Retatrutide is a triple-agonist , meaning it targets three hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Glucagon: affects energy use and fat metabolism Early studies show that retatrutide may be more successful than tirzepatide at managing diabetic kidney disease, as well as for weight control, while tirzepatide may be better at managing blood glucose
Well review your health history, discuss your goals, and let you know if GLP-1 medication is right for you
The goal is finding your therapeutic windowthe dose that delivers meaningful metabolic benefit without compromising quality of life
Aim for at least two to three resistance training sessions per week
20 ArizaM
DISCLAIMER: As with every compounding pharmacy, compounded medications are not FDA-approved and have not been evaluated for safety and efficacy